Innovate company, high barrier to entry/very slim competition & a product that is going to change the way surgeries are performed.

Hold for longer term. Just seems like the way of the future in terms of surgery. this machine does so many prostate and hysterectomy surgery. Really low right here. Sell before their earnings announcement even through they continually beat the street.

Hold for longer term. Just seems like the way of the future in terms of surgery. this machine does so many prostate and hysterectomy surgery. Really low right here. Sell before their earnings announcement even through they continually beat the street.

Companies more expensively valued relative to their R&D, like surgery-robot maker Intuitive Surgical (ISRG) or the operator of Internet-acceleration servers Akamai Technologies (AKAM) offer less scientific bang for the buck.

product, sector and growth rate

They are a sound company with room to grow. baby boomers coming of age its a good sound stock.

The key to this sector is to play on what’s working, explains Quint Tatro. Then stick with it until it doesn’t work any more. I’d look at Intuitive Surgical (ISRG). The stock ramped after hours and held the gains.

Intuitive Surgical dominates the field of robotic-surgery devices, but it's tough to justify the stock's gargantuan multiple

I still can't tell you how I feel about the cancer. But I can tell you about Intuitive. Its stock jumped more than 50 bucks Wednesday, after the Sunnyvale, Calif., company reported better than 50% growth in June-quarter sales and once again beat earnings estimates. At 322 each, the shares now go for more than 75 times trailing 12-month earnings, giving Intuitive one of the handsomest multiples in the Standard & Poor's 500. That multiple reflects the alacrity with which surgeons have adopted the company's da Vinci robot, a four-armed marvel the doctor controls from an operating-room console. Patients have less bleeding and scarring, and can get back on their feet without a long, expensive hospital stay. But Intuitive's volatile and pricey shares also bespeak the desperation of investors mobbing a quality growth story in a lousy economy and stock market. That momentum mob seems heedless of how suddenly this expensive stock could become a victim of the robot's success. You can gauge the market for robotic surgery better than you can for some other new technologies...like Google's, for example. About 40% of the country's large hospitals already have at least one da Vinci robot. When Intuitive (ticker: ISRG) finishes placing its robots, it will see a falloff in the systems sales that have contributed more than half of its revenue. Sales of disposable instruments and accessories for each operation will continue, but the growth rate of those revenues will also decline once the da Vinci gets its share of the relatively fixed number of surgical procedures performed each year.

Oberweis is also a big fan of Intuitive Surgical (ISRG), which he first purchased in July 2005; his fund's average share of Intuitive is up about 285%. Intuitive Surgical developed the minimally invasive da Vinci robotic surgery system, particularly popular for prostate removal. A surgeon sitting at a computer guides tiny robotic arms, equipped with cameras that transmit magnified images, making the operation more precise. More hospitals are buying the $1.6 million systems, Oberweis says. In addition, he notes, recurring revenue from installed surgical supplies continues to climb, and the system is increasingly being adopted for new procedures. Both revenue and profits are growing strongly, he says, justifying the company's high P/E, now 51 times this year's expected $5.46 a share in earnings, and recent stock price of 278.

short

costly mistake

i missed the buy in before it took off

Way overvalued

P/E too high and stock went up too fast

too expensive for now

sold at 100

Stock seems to be falling for no good reason.
I like their products but, I don't enough visibility.

Stock seems to be falling for no good reason.
I like their products but, I don't enough visibility.